Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DM (DTMXF on the OTC): effective Feb. 19,2025 a one for 30 reverse split:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
PARTNER HOLDS 15 MIL SHARES \\// $REGRF
partner
PARTNER HOLDS 15 MIL SHARES \\//
[-chart]www.stockscores.com/chart.asp?TickerSymbol=REGRF&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=None&Indicator3=None&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]
partner
[-chart]www.stockscores.com/chart.asp?TickerSymbol=DTMXF&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=None&Indicator3=None&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]
$DTMXF HOLDS 15 MILLION SHARES OF $REGRF IS THE MOVE EARLY FRIDAY
Symbol
REGRF
Last
$0.0388
Change
+$0.0188 (+94.00%)
Bid
$0.0200
Ask
$0.0575
High
$0.0388
Low
$0.0250
Volume
93,148
Time (ET)
09:36:28 AM
DATAMETREX AI LIMITED 2024 Annual And Special Meeting
Vote by ?November 7, 2024?.
As a shareholder in DATAMETREX AI LIMITED, you have the right to vote in an important election that may affect your investment. Don't miss your chance to make your choice.
Meeting date: ?November 13, 2024?
$DTMXF HOLDS 15 MILLION SHARES OF REGRF, PLUS.
balance sheet $DTMXF
https://www.otcmarkets.com/otcapi/company/financial-report/393593/content
In June 2023, the Company granted 29,500,000 stock options with an exercise price of $0.08 expiring on June 9, 2025.
The options vested immediately. The fair value was calculated to be $1,052,338 using the Black-Scholes option pricing
model with the following assumptions: (1) expected life of the option: 2 years, (2) expected volatility: 78%, (3) expected
dividend yield: 0%, and (4) risk-free interest rate: 4.36%.
In August 2023, the Company granted 5,000,000 stock options with an exercise price of $0.07 expiring on August 14,
2025.
The options vested immediately. The fair value was calculated to be $160,857 using the Black-Scholes option
pricing model with the following assumptions: (1) expected life of the option: 2 years, (2) expected volatility: 81%, (3)
expected dividend yield: 0%, and (4) risk-free interest rate: 4.64%.
During the period ended December 31, 2023, the Company recorded stock-based compensation of $1,213,194 (2022 -
$Nil) related to stock options.
Warrants
On June 18, 2023, a total of 60,000,000 warrants with an exercise price of $0.26 expired. As of December 31, 2023, there
were no warrants issued and outstanding.
Capital management
The Company manages its capital to ensure that it will be able to continue as a going concern while maximizing the return
to stakeholders through a suitable debt and equity balance appropriate for an entity of the Company’s size and status. The
Company’s overall strategy remains unchanged from the prior year.
The capital structure of the Company consists of shareholders’ equity, which totaled $10,328,553 at December 31, 2023
(December 31, 2022 - $22,768,645). The availability of new capital will depend on many factors including positive stock
market conditions, results of operations thereby access to suitable debt products, and the experience of management. The
Company is not subject to any external covenants on its capital.
Acquisitions
Ronin
In January 2019, the Company issued a statement of claim in the Ontario Superior Court of Justice against various vendors
in connection to the Ronin Blockchain Corp. Transaction (“Ronin Vendors”). Some of the defendants have counterclaimed
for shares of the Company allegedly owing under the share purchase agreement, under which the Company acquired Ronin
Blockchain Corp. (subsequently dissolved), as well as damages. The action and counterclaim have not proceeded beyond
the close of pleadings. On March 12, 2019, the Company entered into a final settlement with a 25% owner of the Ronin
Vendors, and issued 2,000,000 common shares in satisfaction of an aggregate of $100,000 of indebtedness. As at
December 31, 2023 and December 31, 2022, claims against the Company from the remaining Ronin Vendors amounted to
a balance of $1,875,000, which is included in “Provisions”.
EVS
In June 2022, the Company completed the acquisition of EVS, an arm’s length privately held electric vehicle charging
solution company incorporated under the laws of the Province of British Columbia, and issued 66,666,667 common shares
(note 10) valued at $9,333,333. The acquisition of EVS was accounted as an asset acquisition. The purchase price of
$9,333,333 was allocated as follows:
Purchase price $ 9,333,333
Patents and developed technologies (note 5) $ 4,272,000
Consideration paid in excess of asset acquired $ 5,061,333
The Company has accounted for the transaction as an asset acquisition under the scope of IFRS 2, Share Based Payments.
Consideration consisted entirely of shares of the Company which were measured at the fair value of assets acquired.
Management determined the fair value of the patents and developed technologies based on an external valuation. The
difference between the fair value of the common shares issued of $9,333,333 and the fair value attributed to the identifiable
intangible assets of $4,272,000 did not meet the criteria for recognition as an asset and consisted of unidentifiable goods
or services, which were recognized at $5,061,333 in profit or loss.
On November 13, 2023, the Company entered into an agreement related to the sale of EVS to New World. Pursuant to the
agreement, New World agreed to acquire EVS for an aggregate purchase price of up to $3,750,000, contingent upon EVS
achieving certain milestones.
The Company may receive up to an additional $3,000,000 in Earn-Out Payments contingent
upon EVS’s fulfillment of certain post-closing performance metrics. Included in amounts receivable at December 31, 2023
was $750,000 related to this sale. The sale resulted in a loss on deconsolidation of $1,972,624, which included cash balance
of $240, intangible assets of $1,419,000, property and equipment of $1,374,542, prepaids and other assets of $228,645 and
accounts payable and accrued liabilities of $299,803.
Imagine Health
In November 2022, the Company entered into a Share Purchase Agreement under which the Company acquired all of the
issued and outstanding shares of Imagine Health located in Calgary, Alberta and Edmonton, Alberta. The purchase price
was as follows: cash payment of $1,300,000 (paid), issuance of 5,000,000 common shares of the Company (issued) (note
10) and the issuance of a secured vendor take-back note with a principal amount of $800,000 payable in installments of 6,
12, and 18 months from the date of issuance (the “Note”) (note 8). The Note is secured by the assets of Imagine Health.
In addition, the Share Purchase Agreement includes a covenant to expand Imagine Health by way of working and growth
capital contribution of up to $1,000,000 to Imagine Health over a period of 12 months from the date of the acquisition.
Subsequent events
In January 2024, the Company granted 22,100,000 restricted share units (“RSU”) in accordance with the Company’s
omnibus incentive plan to employees, directors, and consultants of the Company. Each RSU entitles the holder to acquire
one Common Share on vesting, and the RSUs vest 50% effective immediately, and 50% on April 15, 2024.
The Plan was
approved by the shareholders of the Company at the Annual and Special Meeting Shareholders on December 14,2023.
In February 2024, the Company granted 12,500,000 RSUs to employees, directors, and consultants of the Company.
Each RSU entitles the holder to acquire one Common Share on vesting, and the RSUs vest 12 months from the date of grant.
In February 2024, the Company closed the non-brokered private placement of 50,000,000 units of the Company at a price
of $0.02 per unit for aggregate gross proceeds of $1,000,000.
Each Unit consists of one (1) common share of the Company
("Share") and one (1) common share purchase warrant ("Warrant").
Each Warrant entitles the holder to acquire one
additional Share of the Company at a price of $0.05 per Share for a period of two (2) years from the date of issuance. In
connection with the Private Placement, the Company paid cash finder's fees of $3,200 and issued 160,000 broker warrants
("Broker Warrants") on gross proceeds raised by eligible arm's length parties. Each broker Warrant is exercisable to acquire
one Share of the Company at a price of $0.05 for a period of two (2) years. Insiders of the Company have participated in
the Private Placement by subscribing for 5,250,000 Units.
I HAVE READINGS ON PARTNER $REGRF POSSIBLE $5.00/$6.00 PER SHARE.
AND THE POSSIBILITES FOR $DTMXF
SOME VOLUME TODAY, DM DataMetrex AI Limited
0.01
0.005 (100.00%)
Volume: 1,714,230
Day Range: 0.005 - 0.01
Last Trade Time: 11:40:37 AM EDT
$DTMXF \\// REMEMBER THEY HOLD 15.000,000 SHARES OF $REGRF [REGRF UNLIMITED POSSIBILITIES
I LIKE POSSIBILITES FOR $DTMXF
The possibilities are endless with Datametrex' AI ,,, endless ????? E. V. R. ,,, MEDICAL ,,,
The possibilities are endless with Datametrex' AI ,,, endless ????? E. V. R. ,,, MEDICAL ,,,
READY AIM GO FOR THE MONEY
https://www.stockscores.com/charts/charts/?ticker=DM
https://www.stockscores.com/charts/charts/?ticker=DTPKF
[-chart]www.stockscores.com/chart.asp?TickerSymbol=DTPKF&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=None&Indicator3=None&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]
Yes , True, now 15% $DTMXF ... SHAREHOLDER OF REGRF
do you know what money used for ?????
newbie $DTMXF
after .031 coming nothing - lloks good
may tmr more - let`s gooooo
imo
looks here very super good https://www.otcmarkets.com/stock/DTMXF/quote
imho
super UPTREND CHART now
$DTMXF is now hot - looks epic WEEEEEEEEEEEEEEE🔥
Great volume and first comes volume increase and then price increase.
imo
Nice volume on this AI play, with a great opportunity to load the dip yesterday, green today.
Prior to the Disposition, Datametrex held approximately 18.33% of New World's outstanding common shares. Afterwards, it holds approximately 14.53%.
An interesting Foundation is being-Built-here
This might prove interesting in a few years IMO
Datametrex $DM Financial News https://t.co/S7ggbOB6kH Signs 4 TV clients https://t.co/opmi61y4rF Earns $9.56M on $19M+ in Q1 https://t.co/WYIgu20LYH Secures AI & Tech contracts https://t.co/6eejOYMdCV Deck https://t.co/OGkve5Lonz Site https://t.co/dttPpn8yEQ pic.twitter.com/M0BNGTZlaG
— BUYINS.NET (@buyinsnet) July 23, 2021
Big news today and nice flow of news
If tomorrow we have à gap up watch it explodes
Look at past charts, it seems like it's getting ready for another leg up
Investor Webinar 15 Sep 2020 https://www.datametrex.com/media?wix-vod-video-id=da1e551e92854643aab39b1af2ffa825&wix-vod-comp-id=comp-kedlan3a
Lots of good things ahead for the company.
They are getting up to date with all their filings. Hopefully when all is up to date and reported we should start getting some action and more volume. I’m holding 100k shares for as long as it takes to see this baby grow!
Another 20 filings posted!
https://www.otcmarkets.com/stock/DTMXF/disclosure
I'd be curious if you find ANY OF THE FILINGS of material interest...
The US ticker trades a bit thin, while DM on TSXV has volume.
We’re getting volume in the US. CDN exchange has decent volume.
If we get that kind of avg volume stock would move up a bit.
That’s what it’s going to take to get this stock and company moving. I’m looking for a blowout 3qtr report on sales and revenues.
Followers
|
11
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
179
|
Created
|
12/15/17
|
Type
|
Free
|
Moderators |
Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF)
(the "Company" or "Datametrex'') is pleased to announce that the Company's wholly-owned subsidiary, Nexalogy Environics Inc.
("Nexalogy"), has officially launched its artificial intelligence (AI) and generative pre-trained technology (GPT) software, AnalyticsGPT
to businesses today, designed to empower businesses with the ability to harness the power of AI for data analysis, research and discovery.
The underlying AnalyticsGPT technology was developed in conjunction with and used by the U.S.
and Canadian Military for defense initiatives and is characterized by its robustness, reliability, and precision.
Starting today, enterprises now have access to the new AnalyticsGPT platform, allowing them to leverage this intuitive,
user-friendly interface for their own business needs. In the following weeks, the Company will be announcing additional packages and
pricing models designed to allow smaller businesses to leverage the power of AnalyticsGPT.
In today's data-driven world, businesses face the formidable challenge of navigating the vast sea of online data to make informed decisions
and enhance their bottom line.
AnalyticsGPT was designed to simplify this challenge by offering an efficient
and accessible solution that allows organizations to extract meaningful insights online, conduct thorough research,
discover the unknowns online, and drive data-backed decision-making processes.
Key features of AnalyticsGPT:
*All prices are subject to change without notice and are not guaranteed. Prices stated do not include any sales,
use, vat or excise tax, or any other tax, duty, or charge that is now in effect or may be hereafter imposed
by any Federal, State, Provincial, or other authority.
For further information on AnalyticsGPT, including pricing details, a comprehensive exploration of its features,
a detailed whitepaper, and informative videos that provide an in-depth look into the capabilities of AnalyticsGPT,
please visit the Company's recently updated website at https://www.datametrex.com/analyticsgpt.
" We are excited to officially launch AnalyticsGPT and bring the power of AI-driven data analytics to businesses of all sizes.
Our mission is to simplify the complexities of data analysis and research, enabling businesses to make smarter decisions
and ultimately improve their bottom line. AnalyticsGPT is the result of extensive research and development,
and we believe it will revolutionize the way organizations harness the potential of AI for their business and discovery needs,
" said Marshall Gunter, CEO of the Company.
About Nexalogy
Nexalogy has pioneered AnalyticsGPT, a cutting-edge solution crafted through collaboration with the Canadian government and various private entities.
This technology is designed to distill vast and complex data sets into comprehensible insights.
Powered by proprietary GPT technology, it facilitates swift and cost-effective data scanning.
Users can specify data parameters via keywords and media details. In return, AnalyticsGPT processes this data,
generating automated reports that streamline the interpretation process.
The fusion of advanced A.I. algorithms with GPT technology
makes predictive analytics accessible to a broader audience, removing the typical reliance on specialized data analysts.
Notably, AnalyticsGPT unveils patterns pivotal for both immediate crisis reporting and long-term narrative strategies,
as conceptualized in the BEND (Build Engage Neutralize Distract) framework.
For more information please visit: https://www.datametrex.com/analyticsgpt.
About Datametrex
Datametrex AI Limited is a technology-focused company with verticals in leading industries,
including artificial intelligence, machine learning, telehealth, healthcare, and electric vehicles.
Datametrex's mission is to provide tools and solutions that support companies in optimizing and fulfilling their operational goals,
with predictive and preventive technologies.
By working with companies to set a new standard of protocols through artificial intelligence and health diagnostics,
the Company provides progressive solutions to improve businesses bottom line.
For additional information on Datametrex and other corporate information, please visit the Company's website at http://www.datametrex.com.
To learn more about how our AI is used in Cyber Security, Telehealth and EV,
visit: https://www.youtube.com/watch?v=ApFk3sWAXtg.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |